title: Thiabendazole for the prophylaxis of strongyloidiasis in immunosuppressed patients with hematological diseases: a randomized double-blind placebo-controlled study.
authors.forename: Rodrigo
authors.initials: R
authors.lastname: Portugal
authors.forename: Rony
authors.initials: R
authors.lastname: Schaffel
authors.forename: Leandro
authors.initials: L
authors.lastname: Almeida
authors.forename: Nelson
authors.initials: N
authors.lastname: Spector
authors.forename: Marcio
authors.initials: M
authors.lastname: Nucci
mesh_terms: D000328:Adult; D004311:Double-Blind Method; D005260:Female; D006402:Hematologic Diseases / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D016867:Immunocompromised Host; D008297:Male; D008875:Middle Aged; D013322:Strongyloidiasis / Q000188:drug therapy / Q000517:prevention & control*; D013827:Thiabendazole / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D013827:Thiabendazole